Fleebs-Logo
Details werden geladen...

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems | The Manila Times

Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performance 

Ähnliche Seiten

https://www.manilatimes.net/2026/05/29/tmt-newswire/globenewswire/tonix-pharmaceuticals-presented-retrospective-us-real-world-claims-analysis-of-opioid-use-in-patients-with-fibromyalgia-at-the-2026-american-society-of-clinical-psychopharmacology-ascp-annual-meeting/2354190

Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Mee...

https://www.manilatimes.net/2026/05/29/tmt-newswire/globenewswire/tonix-pharmaceuticals-presented-retrospective-us-real-world-claims-analysis-of-opioid-use-in-patients-with-fibromyalgia-at-the-2026-american-society-of-clinical-psychopharmacology-ascp-annual-meeting/2354190
https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/data-at-ada-2026-highlights-key-findings-from-clinical-and-realworld-studies-of-mannkinds-afrezza-inhaled-insulin-across-pediatric-care-pregnancy-and-use-with-automated-insulin-delivery-aid-systems/2359909

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) ...

https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/data-at-ada-2026-highlights-key-findings-from-clinical-and-realworld-studies-of-mannkinds-afrezza-inhaled-insulin-across-pediatric-care-pregnancy-and-use-with-automated-insulin-delivery-aid-systems/2359909
https://www.manilatimes.net/2026/05/31/tmt-newswire/globenewswire/itm-announces-phase-3-compete-patient-reported-quality-of-life-data-with-nca-lu-edotreotide-itm-11-vs-everolimus-at-asco-2026/2355064

ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026 | The Manila Times

https://www.manilatimes.net/2026/05/31/tmt-newswire/globenewswire/itm-announces-phase-3-compete-patient-reported-quality-of-life-data-with-nca-lu-edotreotide-itm-11-vs-everolimus-at-asco-2026/2355064
https://www.manilatimes.net/2026/06/04/tmt-newswire/globenewswire/alk-will-present-data-on-real-world-use-of-nasal-adrenaline-and-key-learnings-from-20-years-with-slit-tablets-at-eaaci-2026/2358477

ALK will present data on real world-use of nasal adrenaline and key learnings from 20 years with SLIT-tablets at EAACI 2026 | The Manila Times

https://www.manilatimes.net/2026/06/04/tmt-newswire/globenewswire/alk-will-present-data-on-real-world-use-of-nasal-adrenaline-and-key-learnings-from-20-years-with-slit-tablets-at-eaaci-2026/2358477
https://www.manilatimes.net/2026/06/02/tmt-newswire/pr-newswire/finastra-convenes-industry-leaders-in-sydney-to-shape-the-next-era-of-banking-at-innovating-finance-together-summit/2356327

Finastra Convenes Industry Leaders in Sydney to Shape the Next Era of Banking at Innovating Finance Together Summit | The Manila Times

https://www.manilatimes.net/2026/06/02/tmt-newswire/pr-newswire/finastra-convenes-industry-leaders-in-sydney-to-shape-the-next-era-of-banking-at-innovating-finance-together-summit/2356327
https://www.manilatimes.net/2026/05/30/tmt-newswire/globenewswire/impact-biotech-presents-updated-data-from-phase-1-trial-of-padeliporfin-vtp-in-la-pdac-and-phase-3-enlighted-trial-in-lg-utuc-at-asco-2026/2354995

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026 | The Manila Times

https://www.manilatimes.net/2026/05/30/tmt-newswire/globenewswire/impact-biotech-presents-updated-data-from-phase-1-trial-of-padeliporfin-vtp-in-la-pdac-and-phase-3-enlighted-trial-in-lg-utuc-at-asco-2026/2354995